TY - JOUR
T1 - Single-center experience of organ transplant practice during the COVID-19 epidemic
AU - Xu, Jinghong
AU - Han, Ming
AU - Huang, Changjun
AU - Liao, Yuan
AU - Wang, Dongping
AU - Zhu, Xiaofeng
AU - Wang, Changxi
AU - Huang, Jiefu
AU - Guo, Zhiyong
AU - Chen, Guodong
AU - He, Xiaoshun
N1 - Publisher Copyright:
© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd
PY - 2021/10
Y1 - 2021/10
N2 - In order to safely carry out organ donation transplants during the outbreak of coronavirus disease 2019 (COVID-19), we have formulated strict procedures in place for organ donation and transplantation. We retrospectively analyzed our transplantation work from January 20 to May 5, 2020, to discuss whether organ transplantation can be carried out safely during the epidemic period. From January 20 to May 5, 43 cases of donation were carried out in our hospital, and the utilization rate of liver, kidney, heart, lung, and pancreas donations was more than 90%. Forty-one cases of liver transplantation and 84 cases of kidney transplantation were performed. No graft loss or recipient death occurred within one month after kidney transplantation, and one patient (2.4%) died after liver transplantation. There was no significant difference in the length of hospital stay compared with that during the same period in the previous three years. More importantly, COVID-19 infection did not occur among healthcare providers, donors, patients, or their accompanying families in our center. Under the premise of correct protection, it is safe and feasible to carry out organ transplantation during the epidemic period. Our experience during the outbreak might provide a clinical reference for countries facing COVID-19 worldwide.
AB - In order to safely carry out organ donation transplants during the outbreak of coronavirus disease 2019 (COVID-19), we have formulated strict procedures in place for organ donation and transplantation. We retrospectively analyzed our transplantation work from January 20 to May 5, 2020, to discuss whether organ transplantation can be carried out safely during the epidemic period. From January 20 to May 5, 43 cases of donation were carried out in our hospital, and the utilization rate of liver, kidney, heart, lung, and pancreas donations was more than 90%. Forty-one cases of liver transplantation and 84 cases of kidney transplantation were performed. No graft loss or recipient death occurred within one month after kidney transplantation, and one patient (2.4%) died after liver transplantation. There was no significant difference in the length of hospital stay compared with that during the same period in the previous three years. More importantly, COVID-19 infection did not occur among healthcare providers, donors, patients, or their accompanying families in our center. Under the premise of correct protection, it is safe and feasible to carry out organ transplantation during the epidemic period. Our experience during the outbreak might provide a clinical reference for countries facing COVID-19 worldwide.
KW - coronavirus disease 2019
KW - novel coronavirus
KW - organ donation
KW - organ transplantation
KW - COVID-19
KW - Epidemics
KW - SARS-CoV-2
KW - Humans
KW - Tissue and Organ Procurement
KW - Organ Transplantation
KW - Retrospective Studies
KW - Tissue Donors
UR - http://www.scopus.com/inward/record.url?scp=85109959363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109959363&partnerID=8YFLogxK
U2 - 10.1111/tri.13955
DO - 10.1111/tri.13955
M3 - Article
C2 - 34152648
AN - SCOPUS:85109959363
SN - 0934-0874
VL - 34
SP - 1812
EP - 1823
JO - Transplant International
JF - Transplant International
IS - 10
ER -